281 related articles for article (PubMed ID: 12654193)
1. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
Guo ZH; Mei H; Huang J; Li SY
Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
[TBL] [Abstract][Full Text] [Related]
4. [Expression of VEGF and tumor angiogenesis in bladder cancer].
Wang S; Xia T; Zhang Z; Kong X; Zeng L; Mi P; Xue Z
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):34-6. PubMed ID: 11831983
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
[TBL] [Abstract][Full Text] [Related]
6. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
Liu DB; Chen KN; Cao XZ; Wang T
Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
Liu L; Zhu D; Gao R; Guo H
Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
[TBL] [Abstract][Full Text] [Related]
9. [The expression and significance of VEGF mRNA and bFGF mRNA in the malignant neoplasms of ovary].
Li L; Liu YZ; Wu YL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):406-8. PubMed ID: 12206019
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
[TBL] [Abstract][Full Text] [Related]
11. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
Sugamoto T; Tanji N; Sato K; Fujita H; Nishio S; Sakanaka M; Yokoyama M
Anticancer Res; 2001; 21(1A):77-88. PubMed ID: 11299793
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between expression of vascular endothelial growth factor and prognosis of patients with esophageal squamous cell carcinoma].
Hu CZ; Wang YX; Zhang XZ
Ai Zheng; 2002 Mar; 21(3):301-4. PubMed ID: 12452000
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
15. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
Crew JP; Fuggle S; Bicknell R; Cranston DW; de Benedetti A; Harris AL
Br J Cancer; 2000 Jan; 82(1):161-6. PubMed ID: 10638984
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density.
Mattern J; Koomägi R; Volm M
Anticancer Res; 1997; 17(3C):2249-52. PubMed ID: 9216696
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas].
Xu H; Shi XP; Tang WP; Li LX
Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547
[TBL] [Abstract][Full Text] [Related]
19. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
Anticancer Res; 2003; 23(3B):2481-7. PubMed ID: 12894531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
